Takara Bio Inc.
4974.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | ¥112,227,234 | ¥96,814,052 | ¥99,704,028 | ¥126,436,294 |
| - Cash | ¥18,994,000 | ¥22,006,000 | ¥29,549,000 | ¥28,705,000 |
| + Debt | ¥10,000,000 | ¥9,992,000 | ¥1,101,000 | ¥1,287,000 |
| Enterprise Value | ¥103,233,234 | ¥84,800,052 | ¥71,256,028 | ¥99,018,294 |
| Revenue | ¥9,528,000 | ¥9,266,000 | ¥15,757,000 | ¥9,524,000 |
| % Growth | 2.8% | -41.2% | 65.4% | – |
| Gross Profit | ¥5,560,000 | ¥5,004,000 | ¥9,697,000 | ¥3,925,000 |
| % Margin | 58.4% | 54% | 61.5% | 41.2% |
| EBITDA | -¥3,078,000 | -¥305,000 | ¥4,492,000 | -¥570,000 |
| % Margin | -32.3% | -3.3% | 28.5% | -6% |
| Net Income | -¥5,401,000 | -¥1,510,000 | ¥2,420,000 | -¥1,891,000 |
| % Margin | -56.7% | -16.3% | 15.4% | -19.9% |
| EPS Diluted | -44.84 | -12.55 | 20.09 | -15.7 |
| % Growth | -257.3% | -162.5% | 228% | – |
| Operating Cash Flow | ¥1,132,000 | ¥1,912,000 | ¥961,000 | -¥1,216,000 |
| Capital Expenditures | -¥11,779,000 | -¥377,000 | -¥266,000 | -¥8,488,000 |
| Free Cash Flow | -¥10,647,000 | ¥1,535,000 | ¥695,000 | -¥9,704,000 |